Lung Injury Center, Section of Pulmonary and Critical Medicine, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Office N611, Chicago, IL 60637, USA.
Am J Respir Cell Mol Biol. 2012 Mar;46(3):331-41. doi: 10.1165/rcmb.2011-0153OC. Epub 2011 Oct 13.
The generation of phospholipid oxidation products in atherosclerosis, sepsis, and lung pathologies affects endothelial barrier function, which exerts significant consequences on disease outcomes in general. Our group previously showed that oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine (OxPAPC) at low concentrations increases endothelial cell (EC) barrier function, but decreases it at higher concentrations. In this study, we determined the mechanisms responsible for the pulmonary endothelial cell barrier dysfunction induced by high OxPAPC concentrations. OxPAPC at a range of 5-20 μg/ml enhanced EC barriers, as indicated by increased transendothelial electrical resistance. In contrast, higher OxPAPC concentrations (50-100 μg/ml) rapidly increased EC permeability, which was accompanied by increased total cell protein tyrosine (Tyr) phosphorylation, phosphorylation at Tyr-418, the activation of Src kinase, and the phosphorylation of adherens junction (AJ) protein vascular endothelial cadherin (VE-cadherin) at Tyr-731 and Tyr-658, which was not observed in ECs stimulated with low OxPAPC doses. The early tyrosine phosphorylation of VE-cadherin was linked to the dissociation of VE-cadherin-p120-catenin/β-catenin complexes and VE-cadherin internalization, whereas low OxPAPC doses promoted the formation of VE-cadherin-p120-catenin/β-catenin complexes. High but not low doses of OxPAPC increased the production of reactive oxygen species (ROS) and protein oxidation. The inhibition of Src by PP2 and ROS production by N-acetyl cysteine inhibited the disassembly of VE-cadherin-p120-catenin complexes, and attenuated high OxPAPC-induced EC barrier disruption. These results show the differential effects of OxPAPC doses on VE-cadherin-p120-catenin complex assembly and EC barrier function. These data suggest that the rapid tyrosine phosphorylation of VE-cadherin and other potential targets mediated by Src and ROS-dependent mechanisms plays a key role in the dissociation of AJ complexes and EC barrier dysfunction induced by high OxPAPC doses.
在动脉粥样硬化、脓毒症和肺部疾病中,磷脂氧化产物的产生会影响内皮细胞屏障功能,这对总体疾病结果有重大影响。我们的研究小组之前曾表明,低浓度的氧化 1-棕榈酰-2-花生四烯酰基-sn-甘油-3-磷酸胆碱(OxPAPC)可增加内皮细胞(EC)屏障功能,但在更高浓度下则会降低其屏障功能。在这项研究中,我们确定了高浓度 OxPAPC 引起肺内皮细胞屏障功能障碍的机制。在 5-20μg/ml 的范围内,OxPAPC 增强了 EC 屏障,表现为跨内皮电阻增加。相比之下,更高浓度的 OxPAPC(50-100μg/ml)可迅速增加 EC 的通透性,伴随着总细胞蛋白酪氨酸(Tyr)磷酸化、Tyr-418 磷酸化、Src 激酶的激活以及黏着连接(AJ)蛋白血管内皮钙黏蛋白(VE-cadherin)的 Tyr-731 和 Tyr-658 磷酸化,而低浓度 OxPAPC 刺激的 EC 中未观察到这些现象。VE-cadherin 的早期酪氨酸磷酸化与 VE-cadherin-p120-catenin/β-catenin 复合物的解离和 VE-cadherin 的内化有关,而低浓度 OxPAPC 则促进了 VE-cadherin-p120-catenin/β-catenin 复合物的形成。高浓度但不是低浓度的 OxPAPC 增加了活性氧(ROS)和蛋白质氧化的产生。PP2 抑制 Src 和 N-乙酰半胱氨酸抑制 ROS 产生抑制了 VE-cadherin-p120-catenin 复合物的解体,并减轻了高浓度 OxPAPC 诱导的 EC 屏障破坏。这些结果表明 OxPAPC 剂量对 VE-cadherin-p120-catenin 复合物组装和 EC 屏障功能有不同的影响。这些数据表明,Src 和 ROS 依赖性机制介导的 VE-cadherin 快速酪氨酸磷酸化以及其他潜在靶标在 AJ 复合物的解离和高浓度 OxPAPC 诱导的 EC 屏障功能障碍中起关键作用。